Tag: structural heart market emerging trends

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Structural Heart Market Be By 2030 Compared To Its 2026 Market Size?

The structural heart market has experienced robust growth in recent times. Projections indicate that its value will ascend from $15.89 billion in 2025 to $17.31 billion in 2026, registering a compound annual growth rate (CAGR) of 8.9%. This historical expansion is largely due to factors such as the rising incidence of valvular heart conditions, an expanding elderly population worldwide, the proliferation of catheterization facilities, the embrace of transcatheter heart innovations, and heightened understanding of less invasive cardiac treatment options.

The structural heart market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach a valuation of $24.6 billion, demonstrating a compound annual growth rate (CAGR) of 9.2%. This projected growth is driven by several factors, including the increasing demand for transcatheter therapies, greater investments in structural heart initiatives, the proliferation of cardiac centers of excellence, innovations in device miniaturization, and a heightened emphasis on lowering the incidence of open-heart surgeries. Key trends expected during this period involve a wider embrace of transcatheter valve procedures, a surge in the application of minimally invasive structural heart interventions, greater incorporation of advanced cardiac imaging techniques, the proliferation of catheter-based repair innovations, and an intensified focus on tailored patient treatment strategies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

What Key Factors Are Affecting The Structural Heart Market Demand?

The increasing occurrence of cardiovascular disorders is anticipated to fuel the expansion of the structural heart market in the future. These conditions involve illnesses impacting the heart and blood vessels, encompassing ailments like coronary artery disease, heart failure, and stroke. This upward trend in cardiovascular disorders primarily stems from an aging demographic, evolving lifestyle and dietary patterns, and increasing instances of obesity and diabetes. Structural heart devices and related services facilitate the diagnosis and treatment of structural heart anomalies or disorders affecting the valves, chambers, and surrounding tissues. These interventions utilize minimally invasive procedures instead of open-heart surgery, ensuring effective treatment with fewer risks. For example, in September 2025, data from the British Heart Foundation, a charity located in the UK, revealed that over 7.6 million individuals throughout the UK—comprising more than 4 million men and over 3.6 million women—are currently living with cardiovascular disease. Projections further suggest that, influenced by an aging populace and better survival rates, the total number of affected persons could increase by approximately 1 million by 2030 and by around 2 million by 2040. Consequently, the growing incidence of cardiovascular disorders is a significant factor propelling the structural heart market’s growth.

How Is The Structural Heart Market Organized By Segment Classification?

The structural heart market covered in this report is segmented –

1) By Product: Occluders, Annuloplasty Rings, Heart Valve Balloons, Other Products

2) By Procedure: Heart Valve Stenosis, Heart Valve Regurgitation, Left Atrial Appendage Closure

3) By End Users: Hospitals, Cardiac Centers

Subsegments:

1) By Occluders: Atrial Septal Defect (ASD) Occluders, Patent Foramen Ovale (PFO) Occluders, Ventricular Septal Defect (VSD) Occluders

2) By Annuloplasty Rings: Rigid Annuloplasty Rings, Flexible Annuloplasty Rings, Adjustable Annuloplasty Rings

3) By Heart Valve Balloons: Balloon Expandable Heart Valve Systems, Valvuloplasty Balloons

4) By Other Products: Transcatheter Heart Valves, Structural Heart Imaging Devices, Delivery Systems For Structural Heart Procedures

What Trends Are Influencing Changes In The Structural Heart Market?

Leading firms in the structural heart market are creating sophisticated products, such as transcatheter edge-to-edge repair (TEER) systems, to enhance less invasive treatment solutions for heart valve conditions. These transcatheter edge-to-edge repair (TEER) systems are minimally invasive medical devices utilized for treating heart valve diseases, particularly mitral valve regurgitation. For instance, in April 2024, Abbott Laboratories, a US-based medical device company, secured approval from the Food and Drug Administration (FDA), a US-based federal agency tasked with safeguarding public health, for TriClip. TriClip itself is an innovative transcatheter edge-to-edge repair (TEER) system. This less invasive device is introduced via a leg vein, enabling valve repair without the necessity of open-heart surgery, thereby making it appropriate for patients at elevated risk from age or pre-existing health concerns. Its operation involves using clips to grasp and unite the leaflets of the tricuspid valve, which consequently diminishes regurgitation and improves blood flow.

Who Are The Industry Participants Involved In The Structural Heart Market?

Major companies operating in the structural heart market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Lepu Medical Technology Co. Ltd., LivaNova PLC, Venus Medtech (Hangzhou) Inc., CryoLife Inc., Endologix Inc., Braile Biomédica, JenaValve Technology Inc., Corvia Medical Inc., On-X Life Technologies Inc., Symetis SA, Micro Interventional Devices Inc., CardioKinetix Inc., Tendyne Holdings Inc., Neovasc Inc., NVT AG, Biomerics LLC, Shockwave Medical Inc., HLT Medical, Q’Apel Medical Inc., Z-Medical GmbH + Co. KG

Get The Full Structural Heart Market Report:

https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

Which Region Represents The Largest Share Of The Structural Heart Market?

North America was the largest region in the structural heart market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Structural Heart Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

Browse Through More Reports Similar to the Global Structural Heart Market 2026, By The Business Research Company

Structural Heart Market Report 2026

https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

Cardiovascular Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Cardiovascular Implants Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-implants-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Structural Heart Market Be By 2030 Compared To Its 2026 Market Size?

The structural heart market has experienced robust growth in recent times. Projections indicate that its value will ascend from $15.89 billion in 2025 to $17.31 billion in 2026, registering a compound annual growth rate (CAGR) of 8.9%. This historical expansion is largely due to factors such as the rising incidence of valvular heart conditions, an expanding elderly population worldwide, the proliferation of catheterization facilities, the embrace of transcatheter heart innovations, and heightened understanding of less invasive cardiac treatment options.

The structural heart market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach a valuation of $24.6 billion, demonstrating a compound annual growth rate (CAGR) of 9.2%. This projected growth is driven by several factors, including the increasing demand for transcatheter therapies, greater investments in structural heart initiatives, the proliferation of cardiac centers of excellence, innovations in device miniaturization, and a heightened emphasis on lowering the incidence of open-heart surgeries. Key trends expected during this period involve a wider embrace of transcatheter valve procedures, a surge in the application of minimally invasive structural heart interventions, greater incorporation of advanced cardiac imaging techniques, the proliferation of catheter-based repair innovations, and an intensified focus on tailored patient treatment strategies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

What Key Factors Are Affecting The Structural Heart Market Demand?

The increasing occurrence of cardiovascular disorders is anticipated to fuel the expansion of the structural heart market in the future. These conditions involve illnesses impacting the heart and blood vessels, encompassing ailments like coronary artery disease, heart failure, and stroke. This upward trend in cardiovascular disorders primarily stems from an aging demographic, evolving lifestyle and dietary patterns, and increasing instances of obesity and diabetes. Structural heart devices and related services facilitate the diagnosis and treatment of structural heart anomalies or disorders affecting the valves, chambers, and surrounding tissues. These interventions utilize minimally invasive procedures instead of open-heart surgery, ensuring effective treatment with fewer risks. For example, in September 2025, data from the British Heart Foundation, a charity located in the UK, revealed that over 7.6 million individuals throughout the UK—comprising more than 4 million men and over 3.6 million women—are currently living with cardiovascular disease. Projections further suggest that, influenced by an aging populace and better survival rates, the total number of affected persons could increase by approximately 1 million by 2030 and by around 2 million by 2040. Consequently, the growing incidence of cardiovascular disorders is a significant factor propelling the structural heart market’s growth.

How Is The Structural Heart Market Organized By Segment Classification?

The structural heart market covered in this report is segmented –

1) By Product: Occluders, Annuloplasty Rings, Heart Valve Balloons, Other Products

2) By Procedure: Heart Valve Stenosis, Heart Valve Regurgitation, Left Atrial Appendage Closure

3) By End Users: Hospitals, Cardiac Centers

Subsegments:

1) By Occluders: Atrial Septal Defect (ASD) Occluders, Patent Foramen Ovale (PFO) Occluders, Ventricular Septal Defect (VSD) Occluders

2) By Annuloplasty Rings: Rigid Annuloplasty Rings, Flexible Annuloplasty Rings, Adjustable Annuloplasty Rings

3) By Heart Valve Balloons: Balloon Expandable Heart Valve Systems, Valvuloplasty Balloons

4) By Other Products: Transcatheter Heart Valves, Structural Heart Imaging Devices, Delivery Systems For Structural Heart Procedures

What Trends Are Influencing Changes In The Structural Heart Market?

Leading firms in the structural heart market are creating sophisticated products, such as transcatheter edge-to-edge repair (TEER) systems, to enhance less invasive treatment solutions for heart valve conditions. These transcatheter edge-to-edge repair (TEER) systems are minimally invasive medical devices utilized for treating heart valve diseases, particularly mitral valve regurgitation. For instance, in April 2024, Abbott Laboratories, a US-based medical device company, secured approval from the Food and Drug Administration (FDA), a US-based federal agency tasked with safeguarding public health, for TriClip. TriClip itself is an innovative transcatheter edge-to-edge repair (TEER) system. This less invasive device is introduced via a leg vein, enabling valve repair without the necessity of open-heart surgery, thereby making it appropriate for patients at elevated risk from age or pre-existing health concerns. Its operation involves using clips to grasp and unite the leaflets of the tricuspid valve, which consequently diminishes regurgitation and improves blood flow.

Who Are The Industry Participants Involved In The Structural Heart Market?

Major companies operating in the structural heart market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Lepu Medical Technology Co. Ltd., LivaNova PLC, Venus Medtech (Hangzhou) Inc., CryoLife Inc., Endologix Inc., Braile Biomédica, JenaValve Technology Inc., Corvia Medical Inc., On-X Life Technologies Inc., Symetis SA, Micro Interventional Devices Inc., CardioKinetix Inc., Tendyne Holdings Inc., Neovasc Inc., NVT AG, Biomerics LLC, Shockwave Medical Inc., HLT Medical, Q’Apel Medical Inc., Z-Medical GmbH + Co. KG

Get The Full Structural Heart Market Report:

https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

Which Region Represents The Largest Share Of The Structural Heart Market?

North America was the largest region in the structural heart market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Structural Heart Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

Browse Through More Reports Similar to the Global Structural Heart Market 2026, By The Business Research Company

Structural Heart Market Report 2026

https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

Cardiovascular Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Cardiovascular Implants Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-implants-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Structural Heart Market Be By 2030 Compared To Its 2026 Market Size?

The structural heart market has experienced robust growth in recent times. Projections indicate that its value will ascend from $15.89 billion in 2025 to $17.31 billion in 2026, registering a compound annual growth rate (CAGR) of 8.9%. This historical expansion is largely due to factors such as the rising incidence of valvular heart conditions, an expanding elderly population worldwide, the proliferation of catheterization facilities, the embrace of transcatheter heart innovations, and heightened understanding of less invasive cardiac treatment options.

The structural heart market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach a valuation of $24.6 billion, demonstrating a compound annual growth rate (CAGR) of 9.2%. This projected growth is driven by several factors, including the increasing demand for transcatheter therapies, greater investments in structural heart initiatives, the proliferation of cardiac centers of excellence, innovations in device miniaturization, and a heightened emphasis on lowering the incidence of open-heart surgeries. Key trends expected during this period involve a wider embrace of transcatheter valve procedures, a surge in the application of minimally invasive structural heart interventions, greater incorporation of advanced cardiac imaging techniques, the proliferation of catheter-based repair innovations, and an intensified focus on tailored patient treatment strategies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

What Key Factors Are Affecting The Structural Heart Market Demand?

The increasing occurrence of cardiovascular disorders is anticipated to fuel the expansion of the structural heart market in the future. These conditions involve illnesses impacting the heart and blood vessels, encompassing ailments like coronary artery disease, heart failure, and stroke. This upward trend in cardiovascular disorders primarily stems from an aging demographic, evolving lifestyle and dietary patterns, and increasing instances of obesity and diabetes. Structural heart devices and related services facilitate the diagnosis and treatment of structural heart anomalies or disorders affecting the valves, chambers, and surrounding tissues. These interventions utilize minimally invasive procedures instead of open-heart surgery, ensuring effective treatment with fewer risks. For example, in September 2025, data from the British Heart Foundation, a charity located in the UK, revealed that over 7.6 million individuals throughout the UK—comprising more than 4 million men and over 3.6 million women—are currently living with cardiovascular disease. Projections further suggest that, influenced by an aging populace and better survival rates, the total number of affected persons could increase by approximately 1 million by 2030 and by around 2 million by 2040. Consequently, the growing incidence of cardiovascular disorders is a significant factor propelling the structural heart market’s growth.

How Is The Structural Heart Market Organized By Segment Classification?

The structural heart market covered in this report is segmented –

1) By Product: Occluders, Annuloplasty Rings, Heart Valve Balloons, Other Products

2) By Procedure: Heart Valve Stenosis, Heart Valve Regurgitation, Left Atrial Appendage Closure

3) By End Users: Hospitals, Cardiac Centers

Subsegments:

1) By Occluders: Atrial Septal Defect (ASD) Occluders, Patent Foramen Ovale (PFO) Occluders, Ventricular Septal Defect (VSD) Occluders

2) By Annuloplasty Rings: Rigid Annuloplasty Rings, Flexible Annuloplasty Rings, Adjustable Annuloplasty Rings

3) By Heart Valve Balloons: Balloon Expandable Heart Valve Systems, Valvuloplasty Balloons

4) By Other Products: Transcatheter Heart Valves, Structural Heart Imaging Devices, Delivery Systems For Structural Heart Procedures

What Trends Are Influencing Changes In The Structural Heart Market?

Leading firms in the structural heart market are creating sophisticated products, such as transcatheter edge-to-edge repair (TEER) systems, to enhance less invasive treatment solutions for heart valve conditions. These transcatheter edge-to-edge repair (TEER) systems are minimally invasive medical devices utilized for treating heart valve diseases, particularly mitral valve regurgitation. For instance, in April 2024, Abbott Laboratories, a US-based medical device company, secured approval from the Food and Drug Administration (FDA), a US-based federal agency tasked with safeguarding public health, for TriClip. TriClip itself is an innovative transcatheter edge-to-edge repair (TEER) system. This less invasive device is introduced via a leg vein, enabling valve repair without the necessity of open-heart surgery, thereby making it appropriate for patients at elevated risk from age or pre-existing health concerns. Its operation involves using clips to grasp and unite the leaflets of the tricuspid valve, which consequently diminishes regurgitation and improves blood flow.

Who Are The Industry Participants Involved In The Structural Heart Market?

Major companies operating in the structural heart market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Lepu Medical Technology Co. Ltd., LivaNova PLC, Venus Medtech (Hangzhou) Inc., CryoLife Inc., Endologix Inc., Braile Biomédica, JenaValve Technology Inc., Corvia Medical Inc., On-X Life Technologies Inc., Symetis SA, Micro Interventional Devices Inc., CardioKinetix Inc., Tendyne Holdings Inc., Neovasc Inc., NVT AG, Biomerics LLC, Shockwave Medical Inc., HLT Medical, Q’Apel Medical Inc., Z-Medical GmbH + Co. KG

Get The Full Structural Heart Market Report:

https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

Which Region Represents The Largest Share Of The Structural Heart Market?

North America was the largest region in the structural heart market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Structural Heart Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

Browse Through More Reports Similar to the Global Structural Heart Market 2026, By The Business Research Company

Structural Heart Market Report 2026

https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

Cardiovascular Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Cardiovascular Implants Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-implants-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Structural Heart Market From 2026 To 2030?

The structural heart market size has experienced robust expansion in recent years. This market is projected to expand from $15.89 billion in 2025 to $17.31 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.9%. Historically, this growth has been driven by factors such as the increasing incidence of valvular heart diseases, a global aging demographic, the proliferation of catheterization laboratories, the adoption of transcatheter heart technologies, and a growing understanding of the benefits of minimally invasive cardiac care.

The structural heart market size is anticipated to experience robust expansion in the coming years. It is projected to reach $24.6 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.2%. This growth over the forecast period is driven by factors such as an increasing demand for transcatheter therapies, greater investments in structural heart programs, the expansion of cardiac centers of excellence, advancements in device miniaturization, and a heightened emphasis on lowering open-heart surgery rates. Key trends for this period encompass the rising adoption of transcatheter valve procedures, an increase in minimally invasive structural heart interventions, enhanced integration of advanced cardiac imaging, the expansion of catheter-based repair technologies, and a stronger focus on patient-specific treatment planning.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12029&type=smp

What Major Drivers Are Influencing Demand In The Structural Heart Market?

The increasing incidence of cardiovascular ailments is anticipated to fuel the expansion of the structural heart market. These disorders, which impact the heart and blood vessels, encompass conditions such as coronary artery disease, heart failure, and stroke. This surge in prevalence is primarily influenced by an aging demographic, shifts in lifestyle and dietary habits, and escalating rates of obesity and diabetes. Structural heart products and services provide diagnosis and therapy for anomalies or disorders impacting the heart’s valves, chambers, and adjacent tissues, utilizing minimally invasive techniques instead of open-heart surgery, thereby ensuring effective treatment with reduced complication risks. For example, in September 2025, data from the British Heart Foundation, a UK-based charity, revealed that over 7.6 million people across the UK—specifically more than 4 million men and over 3.6 million women—are currently affected by cardiovascular disease. Forecasts suggest that, due to an aging population and enhanced survival rates, this figure could increase by approximately 1 million by 2030 and by around 2 million by 2040. Consequently, the growing occurrence of cardiovascular disorders is propelling the expansion of the structural heart market.

Which Segments Are Included In The Analysis Of The Structural Heart Market?

The structural heart market covered in this report is segmented –

1) By Product: Occluders, Annuloplasty Rings, Heart Valve Balloons, Other Products

2) By Procedure: Heart Valve Stenosis, Heart Valve Regurgitation, Left Atrial Appendage Closure

3) By End Users: Hospitals, Cardiac Centers

Subsegments:

1) By Occluders: Atrial Septal Defect (ASD) Occluders, Patent Foramen Ovale (PFO) Occluders, Ventricular Septal Defect (VSD) Occluders

2) By Annuloplasty Rings: Rigid Annuloplasty Rings, Flexible Annuloplasty Rings, Adjustable Annuloplasty Rings

3) By Heart Valve Balloons: Balloon Expandable Heart Valve Systems, Valvuloplasty Balloons

4) By Other Products: Transcatheter Heart Valves, Structural Heart Imaging Devices, Delivery Systems For Structural Heart Procedures

Which Trends Are Impacting The Growth Of The Structural Heart Market?

Leading companies operating in the structural heart market are developing advanced products, such as transcatheter edge-to-edge repair (TEER) systems, to improve minimally invasive treatment options for heart valve diseases. These TEER systems are minimally invasive medical devices utilized to treat heart valve conditions, especially mitral valve regurgitation. For instance, in April 2024, Abbott Laboratories, a US-based medical device company, obtained approval from the Food and Drug Administration (FDA), a US-based federal agency focused on protecting public health. This approval concerned TriClip, an innovative transcatheter edge-to-edge repair (TEER) system. This minimally invasive device is introduced through a vein in the leg, facilitating valve repair without the necessity of open-heart surgery, thereby making it suitable for patients who might be at higher risk due to age or pre-existing health issues. The device operates by employing clips to grasp and bring together the leaflets of the tricuspid valve, which in turn reduces regurgitation and enhances blood flow.

Which Key Industry Participants Are Active In The Structural Heart Market?

Major companies operating in the structural heart market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Lepu Medical Technology Co. Ltd., LivaNova PLC, Venus Medtech (Hangzhou) Inc., CryoLife Inc., Endologix Inc., Braile Biomédica, JenaValve Technology Inc., Corvia Medical Inc., On-X Life Technologies Inc., Symetis SA, Micro Interventional Devices Inc., CardioKinetix Inc., Tendyne Holdings Inc., Neovasc Inc., NVT AG, Biomerics LLC, Shockwave Medical Inc., HLT Medical, Q’Apel Medical Inc., Z-Medical GmbH + Co. KG

Read the full structural heart market report here:

https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Structural Heart Market?

North America was the largest region in the structural heart market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Structural Heart Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12029&type=smp

Browse Through More Reports Similar to the Global Structural Heart Market 2026, By The Business Research Company

Structural Heart Market Report 2026

https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

Cardiovascular Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Cardiovascular Implants Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-implants-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

How much is the Structural Heart Market valued at in 2026, and what valuation is forecast for 2030?

The structural heart market size has experienced significant expansion in recent years. It is anticipated to expand from $15.89 billion in 2025 to $17.31 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.9%. The market’s historical growth can be attributed to factors such as the increasing occurrence of valvular heart diseases, a globally aging demographic, the proliferation of catheterization laboratories, the acceptance of transcatheter heart technologies, and an escalating understanding of minimally invasive cardiac care.

The structural heart market is projected to experience robust expansion over the coming years. This market is anticipated to reach $24.6 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.2%. Factors driving this growth during the forecast period include the increasing demand for transcatheter therapies, heightened investments in structural heart programs, the proliferation of cardiac centers of excellence, innovations in device miniaturization, and a growing emphasis on lowering open-heart surgery rates. Key trends expected within this period encompass the greater uptake of transcatheter valve procedures, an increase in minimally invasive structural heart interventions, the expanding incorporation of advanced cardiac imaging, the development of catheter-based repair technologies, and a sharpened focus on tailored patient treatment plans.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12029&type=smp

What Drivers Are Influencing The Growth Of The Structural Heart Market?

The anticipated expansion of the structural heart market is linked to the increasing occurrence of cardiovascular disorders. These disorders encompass conditions impacting the heart and blood vessels, such as coronary artery disease, heart failure, and stroke. Key contributors to the growing prevalence of cardiovascular disorders include an aging demographic, evolving lifestyle and dietary habits, and escalating rates of obesity and diabetes. Structural heart solutions, comprising devices and services, facilitate the diagnosis and treatment of heart abnormalities affecting valves, chambers, and adjacent tissues. These involve minimally invasive procedures, offering effective treatment with reduced complication risks compared to open-heart surgery. As an illustration, the British Heart Foundation, a charity in the UK, reported in September 2025 that over 7.6 million individuals across the UK, specifically more than 4 million men and over 3.6 million women, currently suffer from cardiovascular disease. Furthermore, predictions suggest this figure could increase by approximately 1 million by 2030 and about 2 million by 2040, primarily due to an aging population and enhanced survival rates. Consequently, the increased incidence of cardiovascular disorders is a significant impetus for the expansion of the structural heart market.

How Is The Structural Heart Market Organized Into Various Segments?

The structural heart market covered in this report is segmented –

1) By Product: Occluders, Annuloplasty Rings, Heart Valve Balloons, Other Products

2) By Procedure: Heart Valve Stenosis, Heart Valve Regurgitation, Left Atrial Appendage Closure

3) By End Users: Hospitals, Cardiac Centers

Subsegments:

1) By Occluders: Atrial Septal Defect (ASD) Occluders, Patent Foramen Ovale (PFO) Occluders, Ventricular Septal Defect (VSD) Occluders

2) By Annuloplasty Rings: Rigid Annuloplasty Rings, Flexible Annuloplasty Rings, Adjustable Annuloplasty Rings

3) By Heart Valve Balloons: Balloon Expandable Heart Valve Systems, Valvuloplasty Balloons

4) By Other Products: Transcatheter Heart Valves, Structural Heart Imaging Devices, Delivery Systems For Structural Heart Procedures

What Trends Are Reshaping The Dynamics Of The Structural Heart Market?

Major companies in the structural heart market are developing advanced products, such as transcatheter edge-to-edge repair (TEER) systems, to enhance minimally invasive treatment options for heart valve diseases. These TEER systems are minimally invasive medical devices utilized for treating heart valve conditions, particularly mitral valve regurgitation. For instance, in April 2024, Abbott Laboratories, a US-based medical device company, received approval from the Food and Drug Administration (FDA), a US-based federal agency for protecting public health, for its TriClip system. TriClip is an innovative transcatheter edge-to-edge repair (TEER) system. This minimally invasive device is delivered through a vein in the leg, enabling valve repair without the necessity for open-heart surgery, thus making it suitable for patients who might be at higher risk due to their age or existing health problems. The device operates by employing clips to grasp and bring together the leaflets of the tricuspid valve, consequently reducing regurgitation and improving blood flow.

Who Are The Primary Competitors In The Global Structural Heart Market?

Major companies operating in the structural heart market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Lepu Medical Technology Co. Ltd., LivaNova PLC, Venus Medtech (Hangzhou) Inc., CryoLife Inc., Endologix Inc., Braile Biomédica, JenaValve Technology Inc., Corvia Medical Inc., On-X Life Technologies Inc., Symetis SA, Micro Interventional Devices Inc., CardioKinetix Inc., Tendyne Holdings Inc., Neovasc Inc., NVT AG, Biomerics LLC, Shockwave Medical Inc., HLT Medical, Q’Apel Medical Inc., Z-Medical GmbH + Co. KG

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

Which Regions Are Poised For Strategic Growth In The Structural Heart Market?

North America was the largest region in the structural heart market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Structural Heart Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12029&type=smp

Browse Through More Reports Similar to the Global Structural Heart Market 2026, By The Business Research Company

Structural Heart Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

Cardiovascular Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Cardiovascular Implants Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-implants-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the structural heart market from 2025–2034 with trusted insights from The Business Research Company

How Much Will The Structural Heart Market Be Worth By 2029, And What CAGR Will It Achieve?

The structural heart market has experienced substantial growth in recent years. It is anticipated to expand from $14.9 billion in 2024 to $15.89 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.6%. The expansion observed in the past can be attributed to enhanced awareness and screening procedures, strengthened supply chain resilience, increasing healthcare expenditure, market consolidation, and a heightened understanding of cardiovascular diseases.

The structural heart market is projected to experience robust expansion over the coming years, with its size anticipated to reach $22.48 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.1%. This growth during the forecast period is primarily attributed to the increasing demand for heart valve devices, an expanding aging population, the growing burden of cardiovascular diseases, strategic market segmentation, and regional market advancements. Key trends expected over this period include the introduction of new products, continuous technological progress, economic recovery, regulatory measures, the rising incidence of cardiovascular diseases, and the emergence of innovative medical devices.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12029&type=smp

Which Factors Are Driving The Structural Heart Market Forward?

The increasing occurrence of cardiovascular conditions is projected to boost the expansion of the structural heart market. These disorders are illnesses impacting the heart and blood vessels, encompassing ailments like coronary artery disease, heart failure, and stroke. The growing incidence of cardiovascular disorders primarily stems from an aging population, shifts in lifestyle and diet, and rising levels of obesity and diabetes. Structural heart devices and services facilitate the diagnosis and treatment of abnormalities or conditions affecting the valves, chambers, and adjacent tissues of the heart. These procedures are minimally invasive, offering an efficient treatment alternative to open-heart surgery with reduced complication risks. For example, a report from August 2022 by the American College of Cardiology, a US-based non-profit medical association, projects a rise in all four key cardiovascular risk factors in the United States between 2025 and 2060. Diabetes is foreseen to have the most significant percentage increase at 39.3%, reaching 55 million people, followed by dyslipidemia at 27.6% (126 million), hypertension at 25.1% (162 million), and obesity at 18.3% (126 million). Furthermore, researchers noted that the most considerable anticipated increases in specific cardiovascular disease rates are for stroke, with a 33.8% rise to 15 million, and heart failure, increasing by 33.4% to 13 million. Ischemic heart disease is also expected to rise by 30.7% to 29 million, and heart attack by 16.9% to 16 million. Consequently, the increasing occurrence of cardiovascular ailments is fueling the expansion of the structural heart market.

Which Segments Form The Key Structure Of The Structural Heart Market?

The structural heartmarket covered in this report is segmented –

1) By Product: Occluders, Annuloplasty Rings, Heart Valve Balloons, Other Products

2) By Procedure: Heart Valve Stenosis, Heart Valve Regurgitation, Left Atrial Appendage Closure

3) By End Users: Hospitals, Ambulatory Surgical Centers, Cardiac Centers

Subsegments:

1) By Occluders: Atrial Septal Defect (ASD) Occluders, Patent Foramen Ovale (PFO) Occluders, Ventricular Septal Defect (VSD) Occluders

2) By Annuloplasty Rings: Rigid Annuloplasty Rings, Flexible Annuloplasty Rings, Adjustable Annuloplasty Rings

3) By Heart Valve Balloons: Balloon Expandable Heart Valve Systems, Valvuloplasty Balloons

4) By Other Products: Transcatheter Heart Valves, Structural Heart Imaging Devices, Delivery Systems For Structural Heart Procedures

What Strategic Shifts And Innovations Are Influencing The Structural Heart Market?

Technological progress has surfaced as a prominent trend, becoming increasingly prevalent within the structural heart market. Leading companies active in the structural heart sector are focusing their endeavors on developing groundbreaking products to solidify their standing in the market. As an example, during February 2023, Eko Health, a US-based digital health firm, introduced the SENSORA platform, designed for non-invasive cardiac disease detection in primary care settings. SENSORA incorporates artificial intelligence capable of objectively pinpointing structural murmurs, which indicate valvular heart disease, alongside care pathway analytics software. This software offers downstream insight and metrics regarding the patient’s progression through the healthcare system by capturing and analyzing heart sounds and electrical signals using its digital stethoscopes. Its purpose is to assist crucial decision-making by identifying gaps in care, which can lead to improved operational efficiency, including shorter delays in care provision, reduced hospital stays, and lower readmission rates, simultaneously boosting both patient and physician satisfaction.

Which Firms Are Making The Biggest Impact In The Structural Heart Market?

Major companies operating in the structural heart market include Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Trane Technologies, Lepu Medical Technology Co. Ltd., LivaNova PLC, Biomerics LLC, Venus Medtech (Hangzhou) Inc., Cryolife Inc., Endologix Inc., Shockwave Medica Inc., Braile Biomédica, JenaValve Technology Inc., Corvia Medical Inc, HLT Medical, On-X Life Technologies Inc., Symetis SA, Magenta Therapeutics, PASCAL Medical, Micro Interventional Devices Inc., CardioKinetix Inc, Tendyne Holdings Inc., Q’Apel Medical Inc., Neovasc Inc., NVT AG, Z-Medical GmbH + Co. KG

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

Which Region Is Expected To Lead The Structural Heart Market In The Next Few Years?

North America was the largest region in the structural heart market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=12029&type=smp

Browse Through More Reports Similar to the Global Structural Heart Market 2025, By The Business Research Company

Dermatitis Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report

Veterinary Anti Infectives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

Veterinary Infectious Disease Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-infectious-disease-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Structural Heart Market Expected To Expand Between 2025 And 2029?

The valuation of the structural heart segment has experienced robust expansion lately; projections indicate an upward trend moving from a figure of $14.9 billion in 2024 to reach $15.89 billion by 2025, reflecting a consistent annual growth rate of 6.6%. Factors fueling this expansion through the past period include heightened levels of both public consciousness and diagnostic procedures, greater durability within the supply chain, rising outlays on medical services, the consolidation of market players, and a growing understanding regarding ailments of the heart and blood vessels.

Anticipating robust expansion, the overall market for structural heart devices is projected to reach a valuation of 22.48 billion dollars come 2029, achieving a compounded annual growth rate of 9.1% throughout the projection timeframe. This upward trajectory is fundamentally driven by several factors, including the increasing requirement for heart valve replacements, the demographic shift towards an older populace, the escalating prevalence of heart-related ailments, the finer divisions within the market itself, and burgeoning expansion across various geographic sectors. Key developments anticipated to shape this period involve the introduction of new products, continuous progress in medical technology, a rebound in economic conditions, the enforcement of new regulations, a greater frequency of cardiovascular disease occurrences, and the emergence of novel medical instruments.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12029&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Structural Heart Industry?

Anticipated escalation in structural heart market expansion is directly linked to the increasing incidence of ailments affecting the cardiovascular system, encompassing conditions like heart failure, stroke, and coronary artery disease, which impact the heart and its associated vessels. This surge in cardiovascular issues is primarily fueled by demographic shifts towards an older population, evolving dietary habits and life choices, alongside growing obesity and diabetes figures. Structural heart interventions provide a means for diagnosing and treating irregularities in the heart’s chambers, valves, or surrounding structures, generally through less invasive methods compared to traditional open-heart surgery, thereby offering a pathway to effective care with reduced complication risks. To illustrate this trend, data released in August 2022 by the American College of Cardiology, a US-based medical organization, projected that all four significant cardiovascular risk factors in the United States would see an uptick between 2025 and 2060; diabetes is forecasted to have the most significant leap at 39.3%, bringing the total to 55 million people, while dyslipidemia is expected to rise by 27.6% (to 126 million), hypertension by 25.1% (to 162 million), and obesity by 18.3% (to 126 million). Furthermore, researchers noted that projected increases in cardiovascular disease rates were highest for heart failure, anticipated to grow by 33.4% (reaching 13 million cases), and stroke, up by 33.8% (to 15 million), succeeded by ischemic heart disease with a 30.7% increase (to 29 million) and heart attacks increasing by 16.9% (to 16 million), underscoring how the growing burden of cardiovascular disorders stimulates the structural heart market.

What Are The Major Segment Categories Driving The Structural Heart Market Growth?

The structural heartmarket covered in this report is segmented –

1) By Product: Occluders, Annuloplasty Rings, Heart Valve Balloons, Other Products

2) By Procedure: Heart Valve Stenosis, Heart Valve Regurgitation, Left Atrial Appendage Closure

3) By End Users: Hospitals, Ambulatory Surgical Centers, Cardiac Centers

Subsegments:

1) By Occluders: Atrial Septal Defect (ASD) Occluders, Patent Foramen Ovale (PFO) Occluders, Ventricular Septal Defect (VSD) Occluders

2) By Annuloplasty Rings: Rigid Annuloplasty Rings, Flexible Annuloplasty Rings, Adjustable Annuloplasty Rings

3) By Heart Valve Balloons: Balloon Expandable Heart Valve Systems, Valvuloplasty Balloons

4) By Other Products: Transcatheter Heart Valves, Structural Heart Imaging Devices, Delivery Systems For Structural Heart Procedures

How Are Emerging Market Trends Shaping The Structural Heart Industry Landscape?

A pivotal force sweeping through the structural heart arena is the relentless march of technological progress, which is rapidly increasing in prominence. Leading entities within the structural heart sector are intensely focused on the development of novel offerings as means to solidify their competitive standing. A concrete illustration of this is the introduction by Eko Health, a digital health firm based in the United States, in February 2023, of the SENSORA platform, engineered for the non-invasive detection of cardiac diseases within settings of primary care. This SENSORA system incorporates artificial intelligence capabilities designed to impartially pinpoint structural murmurs, which signal the presence of valvular heart disease, alongside software for analyzing the patient care journey. By capturing and analyzing both electrical signals and heart sounds via its digital stethoscopes, this tool furnishes insights and measurements regarding subsequent patient treatment steps across the healthcare continuum. The objective of this technology is to support critical choices by flagging deficiencies in current care protocols, which subsequently stand to improve operational effectiveness—manifesting as shorter wait times for treatment commencement, reduced hospital stays, and fewer readmissions—concurrently boosting contentment levels for both patients and medical practitioners.

Who Are The Core Companies Influencing The Structural Heart Market Landscape?

Major companies operating in the structural heart market include Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Trane Technologies, Lepu Medical Technology Co. Ltd., LivaNova PLC, Biomerics LLC, Venus Medtech (Hangzhou) Inc., Cryolife Inc., Endologix Inc., Shockwave Medica Inc., Braile Biomédica, JenaValve Technology Inc., Corvia Medical Inc, HLT Medical, On-X Life Technologies Inc., Symetis SA, Magenta Therapeutics, PASCAL Medical, Micro Interventional Devices Inc., CardioKinetix Inc, Tendyne Holdings Inc., Q’Apel Medical Inc., Neovasc Inc., NVT AG, Z-Medical GmbH + Co. KG

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Structural Heart Market?

North America was the largest region in the structural heart market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Structural Heart Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12029&type=smp

Browse Through More Reports Similar to the Global Structural Heart Market 2025, By The Business Research Company

Dermatitis Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report

Veterinary Anti Infectives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

Veterinary Infectious Disease Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-infectious-disease-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Structural Heart Market Expected To Expand Between 2025 And 2029?

The valuation of the structural heart segment has experienced robust expansion lately; projections indicate an upward trend moving from a figure of $14.9 billion in 2024 to reach $15.89 billion by 2025, reflecting a consistent annual growth rate of 6.6%. Factors fueling this expansion through the past period include heightened levels of both public consciousness and diagnostic procedures, greater durability within the supply chain, rising outlays on medical services, the consolidation of market players, and a growing understanding regarding ailments of the heart and blood vessels.

Anticipating robust expansion, the overall market for structural heart devices is projected to reach a valuation of 22.48 billion dollars come 2029, achieving a compounded annual growth rate of 9.1% throughout the projection timeframe. This upward trajectory is fundamentally driven by several factors, including the increasing requirement for heart valve replacements, the demographic shift towards an older populace, the escalating prevalence of heart-related ailments, the finer divisions within the market itself, and burgeoning expansion across various geographic sectors. Key developments anticipated to shape this period involve the introduction of new products, continuous progress in medical technology, a rebound in economic conditions, the enforcement of new regulations, a greater frequency of cardiovascular disease occurrences, and the emergence of novel medical instruments.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12029&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Structural Heart Industry?

Anticipated escalation in structural heart market expansion is directly linked to the increasing incidence of ailments affecting the cardiovascular system, encompassing conditions like heart failure, stroke, and coronary artery disease, which impact the heart and its associated vessels. This surge in cardiovascular issues is primarily fueled by demographic shifts towards an older population, evolving dietary habits and life choices, alongside growing obesity and diabetes figures. Structural heart interventions provide a means for diagnosing and treating irregularities in the heart’s chambers, valves, or surrounding structures, generally through less invasive methods compared to traditional open-heart surgery, thereby offering a pathway to effective care with reduced complication risks. To illustrate this trend, data released in August 2022 by the American College of Cardiology, a US-based medical organization, projected that all four significant cardiovascular risk factors in the United States would see an uptick between 2025 and 2060; diabetes is forecasted to have the most significant leap at 39.3%, bringing the total to 55 million people, while dyslipidemia is expected to rise by 27.6% (to 126 million), hypertension by 25.1% (to 162 million), and obesity by 18.3% (to 126 million). Furthermore, researchers noted that projected increases in cardiovascular disease rates were highest for heart failure, anticipated to grow by 33.4% (reaching 13 million cases), and stroke, up by 33.8% (to 15 million), succeeded by ischemic heart disease with a 30.7% increase (to 29 million) and heart attacks increasing by 16.9% (to 16 million), underscoring how the growing burden of cardiovascular disorders stimulates the structural heart market.

What Are The Major Segment Categories Driving The Structural Heart Market Growth?

The structural heartmarket covered in this report is segmented –

1) By Product: Occluders, Annuloplasty Rings, Heart Valve Balloons, Other Products

2) By Procedure: Heart Valve Stenosis, Heart Valve Regurgitation, Left Atrial Appendage Closure

3) By End Users: Hospitals, Ambulatory Surgical Centers, Cardiac Centers

Subsegments:

1) By Occluders: Atrial Septal Defect (ASD) Occluders, Patent Foramen Ovale (PFO) Occluders, Ventricular Septal Defect (VSD) Occluders

2) By Annuloplasty Rings: Rigid Annuloplasty Rings, Flexible Annuloplasty Rings, Adjustable Annuloplasty Rings

3) By Heart Valve Balloons: Balloon Expandable Heart Valve Systems, Valvuloplasty Balloons

4) By Other Products: Transcatheter Heart Valves, Structural Heart Imaging Devices, Delivery Systems For Structural Heart Procedures

How Are Emerging Market Trends Shaping The Structural Heart Industry Landscape?

A pivotal force sweeping through the structural heart arena is the relentless march of technological progress, which is rapidly increasing in prominence. Leading entities within the structural heart sector are intensely focused on the development of novel offerings as means to solidify their competitive standing. A concrete illustration of this is the introduction by Eko Health, a digital health firm based in the United States, in February 2023, of the SENSORA platform, engineered for the non-invasive detection of cardiac diseases within settings of primary care. This SENSORA system incorporates artificial intelligence capabilities designed to impartially pinpoint structural murmurs, which signal the presence of valvular heart disease, alongside software for analyzing the patient care journey. By capturing and analyzing both electrical signals and heart sounds via its digital stethoscopes, this tool furnishes insights and measurements regarding subsequent patient treatment steps across the healthcare continuum. The objective of this technology is to support critical choices by flagging deficiencies in current care protocols, which subsequently stand to improve operational effectiveness—manifesting as shorter wait times for treatment commencement, reduced hospital stays, and fewer readmissions—concurrently boosting contentment levels for both patients and medical practitioners.

Who Are The Core Companies Influencing The Structural Heart Market Landscape?

Major companies operating in the structural heart market include Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Trane Technologies, Lepu Medical Technology Co. Ltd., LivaNova PLC, Biomerics LLC, Venus Medtech (Hangzhou) Inc., Cryolife Inc., Endologix Inc., Shockwave Medica Inc., Braile Biomédica, JenaValve Technology Inc., Corvia Medical Inc, HLT Medical, On-X Life Technologies Inc., Symetis SA, Magenta Therapeutics, PASCAL Medical, Micro Interventional Devices Inc., CardioKinetix Inc, Tendyne Holdings Inc., Q’Apel Medical Inc., Neovasc Inc., NVT AG, Z-Medical GmbH + Co. KG

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Structural Heart Market?

North America was the largest region in the structural heart market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Structural Heart Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12029&type=smp

Browse Through More Reports Similar to the Global Structural Heart Market 2025, By The Business Research Company

Dermatitis Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report

Veterinary Anti Infectives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

Veterinary Infectious Disease Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-infectious-disease-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Current Size And Growth Outlook For The Structural Heart Market?

In the past few years, the structural heart market has seen significant growth. The market, which was valued at $14.9 billion in 2024, is projected to rise to $15.89 billion in 2025 at a Compound Annual Growth Rate (CAGR) of 6.6%. Factors such as heightened awareness and screening, robustness of the supply chain, higher healthcare spending, market consolidation, and rising recognition of cardiovascular diseases have contributed to the impressive growth realized in the previous period.

The size of the structural heart market is projected to experience significant expansion in the coming years. It’s anticipated to increase to a value of $22.48 billion by 2029, with a compound annual growth rate (CAGR) of 9.1%. Factors contributing to this growth during the forecast period include the need for heart valve devices, an aging population, the increasing prevalence of cardiovascular diseases, market segmentation, and regional market expansion. Major trends observed in this period encompass product introductions, advancements in technology, economic rebound, regulatory requirements, growing rates of cardiovascular diseases, and the emergence of novel medical devices.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12029&type=smp

What Growth-Enabling Forces Are Impacting The Structural Heart Market?

The structural heart market is anticipated to experience considerable expansion due to the increasing incidences of cardiovascular disorders. These conditions, which afflict the heart and blood vessels, include ailments like heart failure, stroke, and coronary artery disease. Factors contributing to their rise include an aging populace, evolutionary shifts in lifestyle and diet, and rising obesity and diabetes rates. Structural heart solutions, consisting of devices and services, are employed to diagnose and treat structural heart irregularities impacting the valves, chambers and adjacent tissues, using minimally invasive procedures as an alternate to open-heart surgery. These procedures are aimed at maximizing efficiency while minimizing risk. In August 2022, it was reported by the American College of Cardiology that between 2025 and 2060, all four cardiovascular risk factors are projected to surge in the United States. The steepest rise is predicted in diabetes, with an increase of 39.3% to 55 million individuals. This is then followed by dyslipidemia (27.6% up to 126 million), hypertension (25.1% up to 162 million) and obesity (18.3% up to 126 million). Additionally, it was observed that the likely largest increase in rates of cardiovascular diseases are in stroke (33.8% up to 15 million) and heart failure (33.4% up to 13 million). Ischemic heart disease (30.7% up to 29 million) and heart attacks (16.9% up to 16 million) followed. Consequently, the growing prevalence of cardiovascular ailments is contributing to the expansion of the structural heart market.

How Does The Structural Heart Market Differ By Segment?

The structural heartmarket covered in this report is segmented –

1) By Product: Occluders, Annuloplasty Rings, Heart Valve Balloons, Other Products

2) By Procedure: Heart Valve Stenosis, Heart Valve Regurgitation, Left Atrial Appendage Closure

3) By End Users: Hospitals, Ambulatory Surgical Centers, Cardiac Centers

Subsegments:

1) By Occluders: Atrial Septal Defect (ASD) Occluders, Patent Foramen Ovale (PFO) Occluders, Ventricular Septal Defect (VSD) Occluders

2) By Annuloplasty Rings: Rigid Annuloplasty Rings, Flexible Annuloplasty Rings, Adjustable Annuloplasty Rings

3) By Heart Valve Balloons: Balloon Expandable Heart Valve Systems, Valvuloplasty Balloons

4) By Other Products: Transcatheter Heart Valves, Structural Heart Imaging Devices, Delivery Systems For Structural Heart Procedures

What New Opportunities Are Emerging From Trends In The Structural Heart Market?

The surge in technological advancements has become a prominent trend in the structural heart market, with major players focusing on boosting their market position through innovation. As an exemplification of this trend, Eko Health, a digital health company based in the United States, introduced the SENSORA cardiac disease detection platform in February 2023. The platform targets primary care providing non-invasive detection of heart diseases. SENSORA utilizes artificial intelligence to objectively identify structural murmurs indicative of valvular heart disease. Integrated with care pathway analytics software, this platform offers insight into the patient’s journey throughout the healthcare system by capturing and evaluating heart sounds and electrical signals using its digital stethoscopes. Its aim is to streamline decision-making processes, identify service delivery gaps, and boost operational efficacy, which includes minimizing care delivery delays, hospital stay duration, and readmission frequency, thereby enhancing satisfaction levels for patients and physicians alike.

Who Are The Most Influential Companies In The Structural Heart Market?

Major companies operating in the structural heart market include Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Trane Technologies, Lepu Medical Technology Co. Ltd., LivaNova PLC, Biomerics LLC, Venus Medtech (Hangzhou) Inc., Cryolife Inc., Endologix Inc., Shockwave Medica Inc., Braile Biomédica, JenaValve Technology Inc., Corvia Medical Inc, HLT Medical, On-X Life Technologies Inc., Symetis SA, Magenta Therapeutics, PASCAL Medical, Micro Interventional Devices Inc., CardioKinetix Inc, Tendyne Holdings Inc., Q’Apel Medical Inc., Neovasc Inc., NVT AG, Z-Medical GmbH + Co. KG

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

Which Region Is Leading Innovation In The Structural Heart Market?

North America was the largest region in the structural heart market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=12029&type=smp

Browse Through More Reports Similar to the Global Structural Heart Market 2025, By The Business Research Company

Dermatitis Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report

Veterinary Anti Infectives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

Veterinary Infectious Disease Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-infectious-disease-diagnostics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model